Last edition
News about "Chintu Patel"
Amneal Unveils New Brand to Expand Access to Medicines
The refreshed brand features a new visual identity and “Signature” logo that reflects trust in healthcare, patient impact, and Amneal’s focus on expanding access to medicines across complex therapeutic areas.
Chintu Patel | 15/01/2026 | By News Bureau | 210
Amneal Gains US FDA Approval for Prolia and XGEVA Denosumab Biosimilars
The US FDA approvals for Prolia and XGEVA denosumab biosimilars strengthen Amneal’s growing biosimilars portfolio, with the company planning to commercialise six biosimilars across eight presentations by 2027.
Chintu Patel | 23/12/2025 | By News Bureau | 207
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy